Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001938987 | SCV002200628 | uncertain significance | Renal carnitine transport defect | 2022-08-09 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 131 of the SLC22A5 protein (p.Glu131Lys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1429538). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Giacomini Lab, |
RCV001938987 | SCV002576670 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV001938987 | SCV002816639 | uncertain significance | Renal carnitine transport defect | 2021-11-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003107900 | SCV003761757 | uncertain significance | not provided | 2023-01-25 | criteria provided, single submitter | clinical testing | Described as a non deleterious variant, with functional studies of carnitine uptake by OCNT2 in transfected cells showing no significant difference compared to wildtype (Rodin M et al., 2020); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: Rdin2020[DegreeProject]) |
Genomic Medicine Center of Excellence, |
RCV001938987 | SCV005016525 | uncertain significance | Renal carnitine transport defect | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003107900 | SCV005075097 | uncertain significance | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | SLC22A5: PM2, PP3 |
Breakthrough Genomics, |
RCV003107900 | SCV005188588 | uncertain significance | not provided | criteria provided, single submitter | not provided |